Risedronate is well-tolerated in alendronate-intolerant postmenopausal women.

被引：0
|
作者：
Adachi, J
Adami, S
Miller, P
Olszynski, WP
Kendler, D
Silverman, S
Licata, A
Li, Z
Stevens, K
Long, PH
机构：
[1] Clin Valeggio, Valeggio, Italy
[2] Colorado Ctr Bone Res, Lakewood, CO USA
[3] Midtown Med Ctr, Saskatoon, SK, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[7] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2000年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU401
引用
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [41] The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women
    Yanik, Burcu
    Bavbek, Nukhet
    Yanik, Tugra
    Inegol, Ilknur
    Kanbay, Mehmet
    Turgut, Faruk Hilmi
    Uz, Ebru
    Akcay, Ali
    [J]. RENAL FAILURE, 2007, 29 (04) : 471 - 476
  • [42] DIFFERENCES IN EARLY DYNAMICS OF SERUM BONE MARKERS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED BY ALENDRONATE OR RISEDRONATE
    Sferrazza, C.
    Carmina, E.
    Cannone, V.
    Avila, D.
    Sutera, L.
    Rini, G. B.
    Di Fede, G.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S97 - S97
  • [43] Rapid and consistent effect of risedronate on vertebral fracture risk reduction in elderly postmenopausal women.
    Greenwald, M
    Fischer, M
    Poiley, J
    Bos, K
    Reginster, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S226 - S226
  • [44] Risedronate 35 mg once a week is as effective as 5 mg daily in postmenopausal women.
    Lindsay, R
    Kendler, D
    McClung, MR
    Balske, A
    Li, ZQ
    Brown, J
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S153 - S153
  • [45] Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in postmenopausal women.
    Byun, D.
    Mok, J.
    Lee, K.
    Won, J.
    Kim, Y.
    Park, H.
    Kim, C.
    Kim, S.
    Suh, K.
    Yoo, M.
    Ryu, C.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S413 - S413
  • [46] Letrozole effective, well tolerated in postmenopausal women with advanced breast cancer
    不详
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (03): : 324 - 324
  • [47] Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study
    Hejdova, M
    Palicka, V
    Kucera, Z
    Vlcek, J
    [J]. PHARMACY WORLD & SCIENCE, 2005, 27 (03): : 149 - 153
  • [48] Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study
    Miroslava Hejdova
    Vladimir Palicka
    Zdenek Kucera
    Jiri Vlcek
    [J]. Pharmacy World and Science, 2005, 27 : 149 - 153
  • [49] Women with postmenopausal osteoporosis or osteopenia previously receiving weekly alendronate or risedronate are more satisfied with monthly ibandronate
    Bonnick, S. L.
    Martens, M.
    Civitelli, R.
    Friend, K. E.
    Silverman, S.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S118 - S119
  • [50] Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
    M. L. Frost
    M. Siddique
    G. M. Blake
    A. E. Moore
    P. K. Marsden
    P. J. Schleyer
    R. Eastell
    I. Fogelman
    [J]. Osteoporosis International, 2012, 23 : 2107 - 2116
12345